Chemotherapeutic evaluation of n-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3335-3339

  Abou issa, Hussein ^a,c   Curley Jr , Robert W ^a   Panigot, Michael J ^b   Tanagho, Sharif N ^a   Sidhu, Balvinder S ^a   Alshafie, Galal A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MARSHALL UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Glucuronide derivative; N (4 hydroxyphenyl) retinamide; Rat mammary tumor model

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; FENRETINIDE; GLUCURONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENCY; FEMALE; MAXIMUM PERMISSIBLE DOSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TUMOR REGRESSION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BODY WEIGHT; FEMALE; FENRETINIDE; GLUCURONATES; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030785296     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Abou-Issa H, Curley RW, Panigot MJ, Wilcox KA and Webb TE: In vivo use of N-(4hydroxyphenyl) retinamide-O-glucuronide as breast cancer chemopreventive agent. Anticancer Res 13: 1431-1436, 1993.
2. Mehta RG, Barua AB, Olson JA and Moon RC Effect of retinoid glucuronides on mammary gland development in organ culture. Oncology 48: 505-509, 1991.
3. Zile MH, Cullum ME, Simpson RU, Barua AB and Swartz DA: Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide; a biologically active metabolite of vitamin A. Proc Natl Acad Sci. USA 84: 2208-2212, 1987.
4. Robarge MJ, Repa JJ, Hanson KK, Seth S, Clagett-Dame M, Abou-Issa H and Curley RW: N-linked analogs of retinoid O-glucuronides; potential cancer chemopreventive/ chemotherapeutic agents. Bioorg Med Chem Lett 4: 2117-2122, 1994.
5. Barua AB and Olson JA: The chemical synthesis and characterization of retinoyl ß-glucuronide. Fed Proc Fed Am Soc Exp Biol 44: 772, 1985.
6. Sietsema WK and Deluca HF: A new vaginal smear assay for Vitamin A in rats. J Nutr 112: 1481-1489 1982.
7. Gallup J, Barua A, Furr A and Olson JA: Effects of retinoid-ß-glucuronides and N-retinoyl amines on the differentiation of HL-60 cells in vitro. Proc Soc Exptl Biol Med 186: 269-274, 1987.
8. Gunning DB, Barua AB and Olson JA: Comparative teratogenicity and metabolism of all-trans retinoic acid, all-trans retinoyl-β-glucuronide in pregnant Sprague-Dawley rats. Teratology 47: 29-36, 1993.
9. Bhatnagar R, Abou-Issa H, Curley RW, Koolemans-Beynen A, Moeschberger M and Webb TE: Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl) retinamide, its glucuronide and through synergism with glucurate. Biochem Pharmacol 41: 1471-1477, 1991.
10. Shibasaki J, Sadakane E, Konish R and Koizumi T: Drug absorption, metabolism and excretion. VI. Preparation of ether-type glucuronide of 4-hydroxyacetanilide. Chem Pharm Bull (Tokyo) 18: 2340-2343, 1970.
11. Dawson MI and Hobbs PD: Synthesis of the D-glucuronic acid conjugates of N-(4-hydroxyphenyl) retinamides and N-(2-hydroxyethyl) retinamides. Carbohydr Res 85: 121-129, 1980.
12. Huggins C, Grand LC and Brillantes F. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 185: 204-207, 1961.
13. Abou-Issa H, Duruible V, Minton JP, Larroya S, Dwivedi C and Webb TE: Putative metabolites derived from dietary combinations of calcium glucurate and N-(4-hydroxyphenyl) retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz(a)anthracene. Proc Natl Acad Sci USA 85: 4181-4184, 1988.
14. Steel GG: Growth kinetics oftumors. Oxford Univ. Press, London 1977, pp 5-25.
15. Klurfeld DM, Welch CB, Davis MJ et al: Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J Nutr 119: 286-291, 1989.
16. Kaiser-Kupfer MI, Peck GL, Caruso RC et al: Abnormal retinal function associated with fenretinide, a synthetic retinoid. Arch Opthalmol 104: 67-70, 1986.
17. Modiano MR, Dalton WS, Lippman SM et al: Ocular toxic effects of fenretinide. J Natl Cancer Inst 82: 1063, 1990.
18. 3H) retinoyl-β-glucuronide and its metabolism in rats in vivo. Biochem J 263: 403-409, 1989.
19. Zile MH, Inhorn RC and DeLuca H: Metabolism of retinoic acid in bile; Identification for all-trans and 13-cis-retinoyl-β-glucuronides. J Biol Chem 257: 3537-3543, 1982.
20. Swanson B, Newton DL, Roller PP and Sporn MB: Biotransformation and biological activity of N-(4-hydroxyphenyl) retinamide derivatives in rodents. J Pharmacol Exp Ther 279: 632-637, 1981.
21. Stolfi RL, Stolfi LM, Sawyer RC et al: Chemotherapeutic evaluation using clinical criteria in spontaneous autochthonous murine breast tumors. J Natl Cancer Inst 8: 52-55, 1988.
22. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605: 33-91, 1980.
23. Dowlatshahi K, Mehta RG, Thomas CF, Digner NM and Moon RC: Therapeutic effect of N-(4-hydroxyphenyl) retinamide on N-methyl-N-nitrosourea induced rat mammary cancer. Cancer Lett 47: 187-192, 1989.
24. Schleicher R, Moon RC, Patel MK and Beattie CW: Infiuence of retinoids on growth and metastasis of hamster melanoma in athymic mice. Cancer Res 48: 1465-1469, 1988.
25. Hill DL and Grubb CJ: Retinoids as chemopreventive and anticancer agents in intact animals. Anticancer Res 2: 111-124, 1982.
26. 3H - all-trans retinyl β-glucuronide in rats in vivo. Biochem. J. 252: 415-420, 1988.
27. Gigure V: Retinoic acid receptors and cellular retinoid binding proteins; complex interplay in retinoid signaling. Endocrine Revs 15: 61-79, 1994.
28. Curley RW, Abou-Issa H, Panigot MJ, Repa JJ, Calgett-Dame M and Alshafie G. Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-O-glucuronides against breast cancer development and growth. Anticancer Res 16: 757-764, 1996.
29. Sani BP, Barua AB, Hill DL, Shih T-W and Olson JA: Retinoyl ß-glucuronide: Lack of binding to receptor proteins of retinoic acid as related to biological activity. Biochem. Pharmacol 43: 919-922, 1992.
30. Formelli F, Cassana R, Costa A et al: Plasma retinol level reduction by the synthetic retinoid fenretinide; A one year follow-up study of breast cancer patients. Cancer Res 49: 6149-6152, 1989.
31. Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Formelli F, Menard S, Costa A, Veronesi U, Pierotti M: N-(4- hydroxyphenyl) retinamide induces apoptosis of malignant hematopoietic cell lines including those unresponsive to retinoic acid. Cancer Res. 53: 6036-6041, 1993.
32. Abou-Issa H, Dwivedi C, Curley RW, Kirkpatrick R, Koolemans-Beyen A, Engineer F, Humphries KA, El-Masry W and Webb TE. Basis for the antitumor and chemopreventive activities of glucarate and the glucarate:retinoid combination. Anticancer Res 13: 395-400, 1993.
33. Abou-Issa H and Duruibe V. Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction and its relationship to cyclic AMP-dependent protein kinase. Biochem Biophys Res Commun 135: 116-123, 1986.